Michael Schmertzler, Director at PTC THERAPEUTICS, INC. (PTCT), sold 2,500 shares at $63.38 ($158K) on 2026-10-07, disclosed to the SEC on 2026-10-09.
Scheduled sale ($158k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.38 | 2,447 | $155K | 97.9% |
| 2 | $63.95 | 53 | $3K | 2.1% |
| Total | $63.39 avg | 2,500 | $158K | 100% |
| Filing → |
| PTCT | SELL | 2026-09-11 | $1.4M | — | Filing → |
| PTCT | SELL | 2026-08-28 | $1.8M | — | Filing → |
| PTCT | SELL | 2026-08-21 | $1.8M | — | Filing → |